CYTORI THERAPEUTICS INC's ticker is CYTX and the CUSIP is 23283K105. A total of 77 filers reported holding CYTORI THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 4.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $103,000 | +14.4% | 484,290 | -0.1% | 0.07% | +14.3% |
| Q4 2015 | $90,000 | -48.0% | 484,890 | -4.8% | 0.06% | -40.0% |
| Q3 2015 | $173,000 | -39.1% | 509,490 | 0.0% | 0.10% | -30.0% |
| Q2 2015 | $284,000 | -41.2% | 509,490 | +24.4% | 0.15% | -39.3% |
| Q1 2015 | $483,000 | +182.5% | 409,490 | +16.7% | 0.25% | +160.0% |
| Q4 2014 | $171,000 | -38.9% | 350,890 | -15.1% | 0.10% | -46.9% |
| Q3 2014 | $280,000 | -75.3% | 413,490 | -12.9% | 0.18% | -77.2% |
| Q2 2014 | $1,135,000 | -5.6% | 474,805 | +6.6% | 0.78% | -10.0% |
| Q1 2014 | $1,202,000 | +33.9% | 445,315 | +27.4% | 0.87% | +21.4% |
| Q4 2013 | $898,000 | +25.8% | 349,405 | +13.9% | 0.72% | +10.1% |
| Q3 2013 | $714,000 | +30.1% | 306,645 | +28.4% | 0.65% | +23.7% |
| Q2 2013 | $549,000 | – | 238,790 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 926,000 | $626,000 | 0.56% |
| GOLDMAN CAPITAL MANAGEMENT INC | 1,609,576 | $1,095,000 | 0.55% |
| PERKINS CAPITAL MANAGEMENT INC | 663,895 | $449,000 | 0.38% |
| PRINCETON CAPITAL MANAGEMENT INC | 413,490 | $280,000 | 0.18% |
| Redmond Asset Management, LLC | 302,621 | $205,000 | 0.11% |
| SABBY MANAGEMENT, LLC | 3,495,368 | $2,363,000 | 0.09% |
| Noven Financial Group, Inc. | 52,705 | $36,000 | 0.03% |
| GAGNON SECURITIES LLC | 56,439 | $38,000 | 0.01% |
| Dominick & Dominick LLC | 24,350 | $16,000 | 0.01% |
| THOMPSON DAVIS & CO., INC. | 5,500 | $4,000 | 0.01% |